JULI1000

About this trial

Last updated 3 years ago

Study ID

JULI1000

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

Accepting

21+ Years

All

Not accepting

Healthy Volunteers

Trial Timing

Ended 4 months ago

The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.

Inclusion Criteria

- 21 years of age or older

- Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis

- Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app.